MindBio Raises $1.44 Million and Launches Marketing Push for Intoxication Detection Tech

Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has issued an update.

MindBio Therapeutics has closed an upsized non-brokered private placement, raising approximately $1.44 million through the issuance of 2.4 million units priced at $0.60, each comprising a common share and a warrant exercisable at $0.80. The company plans to use the funds to accelerate development and deployment of proprietary hardware and edge technology for remote intoxication detection in mining operations, support recruitment applications, and bolster working capital, while also engaging The Market Link and Investor Brand Network in year-long campaigns to boost market visibility and investor awareness without issuing equity compensation.

In connection with the financing, MindBio paid cash finder fees and issued finder warrants with similar terms to the placement warrants, all subject to standard resale restrictions and final regulatory approvals. The parallel promotional agreements are aimed at expanding public awareness and distribution of the company’s news across advertising, media, and social channels, signalling a coordinated push to strengthen its market presence as it advances commercialisation of its AI-driven safety technology.

More about Mindbio Therapeutics Corp.

MindBio Therapeutics Corp. is a biotechnology company focused on commercialising prediction technologies for detecting drug and alcohol intoxication using speech analytics and artificial intelligence. The company is developing proprietary hardware and edge technology to enable remote and scalable deployment of its intoxication detection solutions, with an initial market focus on industrial environments such as mining sites and specialised workforce recruitment.

Average Trading Volume: 11,726

Technical Sentiment Signal: Sell

Current Market Cap: C$5.99M

See more insights into MBIO stock on TipRanks’ Stock Analysis page.